Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class ASSE: 603392

Announcement on Approval for Clinical Trials of the Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)

· Issued by Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Approval for Clinical Trials of the Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment